Lê A D, Khanna J M, Kalant H, LeBlanc A E
Psychopharmacology (Berl). 1980 Feb;67(2):143-6. doi: 10.1007/BF00431969.
5,7-Dihydroxytryptamine (5,7-DHT) or the vehicle was administered once into both lateral ventricles of the rat. Desmethylimipramine (DMI) was administered IP prior to the intraventricular injection of 5,7-DHT to prevent the destruction of norepinephrine (NE) terminals. Following recovery from surgery, ethanol (5 g/kg, PO) or isocaloric sucrose was given daily for 25 days. Tests at 5-day intervals showed that chronic ethanol treatment produced tolerance to the motor impairment on the moving belt test and to hypothermic effects of ethanol. The 5,7-DHT treatment did not alter either the motor impairment or hypothermia produced by the initial dose of ethanol. However, 5,7-DHT treatment produced a 75% depletion of brain serotonin (5-HT) without altering NE concentration and retarded the development of tolerance to ethanol in both measurements. This study with a specific central depletor of 5-HT, without alteration in NE concentration, extends and supports our hypothesis that brain 5-HT modulates the development of tolerance to ethanol.
将5,7 - 二羟基色胺(5,7 - DHT)或赋形剂一次性注入大鼠双侧侧脑室。在脑室内注射5,7 - DHT之前腹腔注射去甲丙咪嗪(DMI),以防止去甲肾上腺素(NE)终末被破坏。术后恢复后,每天给予乙醇(5克/千克,口服)或等热量的蔗糖,持续25天。每隔5天进行的测试表明,慢性乙醇处理使大鼠对移动带试验中的运动障碍以及乙醇的体温降低作用产生耐受性。5,7 - DHT处理既未改变初始剂量乙醇所致的运动障碍,也未改变体温降低。然而,5,7 - DHT处理使脑内5 - 羟色胺(5 - HT)耗竭75%,而不改变NE浓度,并且在两项测量中均延缓了对乙醇耐受性的发展。这项使用特异性5 - HT中枢耗竭剂且不改变NE浓度的研究扩展并支持了我们的假说,即脑内5 - HT调节对乙醇耐受性的发展。